IV Daratumumab versus Subcutaneous Daratumumab

IV Daratumumab versus Subcutaneous Daratumumab

obr

11 months
116 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Saad Usmani, MD, Chief, Plasma Cell Disorders Program, Hematologic Malignancies, Levine Cancer Institute/Atrium Health, UNC Chapel Hill School of Medicine, compares intravenous daratumumab versus subcutaneous daratumumab.
Up Next Autoplay